The Impact of Pathological Tumor Regression and Nodal Status on Survival and Systemic Disease in Patients Undergoing Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma

@article{Miyata2018TheIO,
  title={The Impact of Pathological Tumor Regression and Nodal Status on Survival and Systemic Disease in Patients Undergoing Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma},
  author={Hiroshi Miyata and Koji Tanaka and Tomoki Makino and Makoto Yamasaki and Yasuhiro Miyazaki and Tsuyoshi Takahashi and Yukinori Kurokawa and Kiyokazu Nakajima and Shuji Takiguchi and Eiichi Morii and Masaki Mori and Yuichiro Doki},
  journal={Annals of Surgical Oncology},
  year={2018},
  volume={25},
  pages={2409-2417}
}
BackgroundAlthough tumor regression and nodal status are reported to be useful prognostic factors for patients with oesophageal cancer who are treated with neoadjuvant chemoradiotherapy, the clinical effects of those factors remain to be explained fully in neoadjuvant chemotherapy. Additionally, factor predictive of systemic disease after neoadjuvant therapy remain unexplored.MethodsThe impact of pathological tumor regression and the number of involved lymph nodes on survival and the occurrence… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 33 REFERENCES

A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction

F Klevebro, G Alexandersson von Döbeln
  • Ann Oncol
  • 2016
VIEW 1 EXCERPT

Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2016
VIEW 1 EXCERPT

Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2014
VIEW 1 EXCERPT